Lonza keeps adding on as it looks to beef up biologics offering, tacking on nearly $1B in expansions in EU, US
Amid a flurry of expansion activity, CDMO Lonza is continuing to beef up its manufacturing plants both in its native Switzerland and in the US …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
